CIK 0001053691 · Non-accelerated filer<br>Smaller reporting company
CervoMed Inc.
Sign in to watch- Ticker
- CRVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 300645032
- Phone
- (617) 744-4400
- Business address
- 20 PARK PLAZA, SUITE 424, BOSTON, MA, 02116
- Former names
- Diffusion Pharmaceuticals Inc., RestorGenex Corp, Stratus Media Group, Inc, FERIS INTERNATIONAL, INC., TITAN MOTORCYCLE CO OF AMERICA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-08-31 | BLECH ISAAC Director | Grant or award · Stock Option (Right to Buy) | +204,907 | 204,907 | ||
| 2016-07-21 | LEVIN ALAN G Director | Grant or award · Stock Option (Right to Buy) | +58,473 | 58,473 | ||
| 2016-07-21 | Giles Mark T Director | Grant or award · Stock Option (Right to Buy) | +58,473 | 58,473 | ||
| 2016-07-21 | Adams Robert W Director | Grant or award · Stock Option (Right to Buy) | +58,473 | 58,473 | ||
| 2016-05-16 | Byrne Thomas E General Counsel | Grant or award · Stock Option (Right to Buy) | +16,667 | 16,667 | ||
| 2016-05-16 | Kalergis David G Chairman and CEO | Grant or award · Stock Option (Right to Buy) | +204,167 | 204,167 | ||
| 2016-05-16 | Shealy Ben Senior Vice President Finance | Grant or award · Stock Option (Right to Buy) | +89,583 | 89,583 | ||
| 2016-05-16 | Gainer John Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +83,333 | 83,333 | ||
| 2016-01-08 | Kalergis David G Chairman and CEO | Grant or award | +1,069,216 | 1,069,216 | ||
| 2016-01-08 | Kalergis David G Chairman and CEO | Grant or award | +215,506 | 215,506 | ||
| 2016-01-08 | Kalergis David G Chairman and CEO | Grant or award · Stock Option (Right to Buy) | +295,865 | 295,865 | ||
| 2016-01-08 | Kalergis David G Chairman and CEO | Grant or award · Stock Option (Right to Buy) | +91,316 | 91,316 | ||
| 2016-01-08 | Kalergis David G Chairman and CEO | Grant or award · Stock Option (Right to Buy) | +273,949 | 273,949 | ||
| 2016-01-08 | Kalergis David G Chairman and CEO | Grant or award · Stock Option (Right to Buy) | +127,843 | 127,843 | ||
| 2016-01-08 | Kalergis David G Chairman and CEO | Grant or award · Stock Option (Right to Buy) | +182,632 | 182,632 | ||
| 2016-01-08 | Kalergis David G Chairman and CEO | Grant or award · Stock Option (Right to Buy) | +182,632 | 182,632 | ||
| 2016-01-08 | Kalergis David G Chairman and CEO | Grant or award · Stock Option (Right to Buy) | +127,843 | 127,843 | ||
| 2016-01-08 | Kalergis David G Chairman and CEO | Grant or award · Stock Option (Right to Buy) | +365,265 | 365,265 | ||
| 2016-01-08 | Kalergis David G Chairman and CEO | Grant or award · Stock Option (Right to Buy) | +331,595 | 331,595 | ||
| 2016-01-08 | Byrne Thomas S Director | Grant or award | +1,391,867 | 1,391,867 |
Page 12 of 17 · 321 trades